About CML Lysosomal Storage Diseases

About

 
The educational mission of Current Medical Literature – Lysosomal Storage Diseases is to provide clinicians and allied healthcare professionals involved in the care of patients with lysosomal storage diseases with access to expert commentary and analysis on topical, clinically relevant, and practical issues in this field. CML – Lysosomal Storage Diseases contains in-depth review articles written by international experts providing insight into specific educational themes with clearly defined learning objectives. All articles undergo rigorous peer-review prior to being accepted for publication. Each issue also contains critical reviews of the recently published articles of most importance and relevance written by practicing clinicians.
 
Leading Articles: Our Leading Articles are in-depth reviews commissioned from renowned experts. They are written to provide insight into specific educational themes identified through collaboration with the journal's Editorial Board and the CML editorial team. The topics are chosen in response to advances in the understanding, treatment, and management of patients, taking into account suggestions and feedback from readers and aiming to anticipate important issues arising in the field.
 
Clinical Reviews: The Editors of Current Medical Literature – Lysosomal Storage Diseases identify the articles of most importance and relevance published in the international literature each quarter. They then prepare concise and critical analyses of these articles, discussing the research findings and explaining the importance of the results in a clinical context.
 
Editorial control is the responsibility of the Editorial Advisory Board, the Clinical Editors and the Publisher. Before publication, all material submitted to the journal is subjected to rigorous review by the Editorial Advisory Board, Clinical Editors, and/or independent reviewers for suitability of scientific content, scientific accuracy, scientific quality, and conflict of interest.
 

Acknowledgement


The Current Medical Literature team would like to thank the following publishers for granting us access to their online journal content:
 
JAMA
The New England Journal of Medicine
 

Correspondence


The Editors look forward to receiving suggestions from readers regarding current articles they think deserve to be featured and which may have been omitted, and on any matter which might improve the series. Please address all correspondence to:
 
Current Medical Literature, Remedica Education and Publishing, 5-6 Underhill Street, London, NW1 7HS, UK, Tel: +44 (0)20 7428 2999, Fax: +44 (0)20 7428 2951, Email: info@remedicajournals.com
 
Editor: George Posford
Editorial Manager: Clare Byrne
Production Manager: Mary Hughes
Design and Artwork: AS&K Communications Ltd
 

Publisher’s Statement


© Remedica 2002–2013. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without the prior permission of the copyright owners. While every effort is made by the publishers and editorial board to see that no inaccurate or misleading data, opinions, or statements appear in this journal, they wish to make it clear that the material contained in the publication represents a summary of the independent evaluations and opinions of the authors and contributors. As a consequence, the board, publishers, and any supporting company accept no responsibility for the consequences of any such inaccurate or misleading data or statements. Neither do they endorse the content of the publication or the use of any drug or device in a way that lies outside its current licensed application in any territory. For detailed information on any drugs or devices discussed in this publication, readers are advised to consult the manufacturer’s prescribing information.
 
ISSN 1473–0901 (Print)
ISSN 1759–8133 (Online) 
 

READER POLL

CML LSD poll 1
What type of therapy do you believe holds the most promise for the successful treatment of lysosomal storage diseases in the future?







Powered by NetPolls

SUBMIT AN ARTICLE